The Capillary Index Score Trial

Firas Al-Ali57 enrolled

Overview

This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS). The hypothesis or idea being tested: Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.

This study is trying to look at how the well-being of the patient following treatment is influenced by peripheral blood supply (collateral flow) to the area lacking primary blood flow due to the clot. Treatment of AIS includes EVT and medical treatment. EVT is typically not offered to patients after 6 hours of the onset of symptoms. The current study is based on the belief that patients can be successfully treated with the EVT up to 8 hours, as long as they have good peripheral blood flow (collateral flow) to the area of tissue blocked of the primary blood supply. The study will evaluate the ability of the capillar index score (CIS) to identify patients who can be successfully treated with EVT. The CIS quantifies blood supply to the ischemic area from peripheral vessels (collateral flow) based on diagnostic cerebral angiogram. Patients are graded on a scale from 0-3, with 0 and 1 considered a poor CIS (pCIS) and 2 and 3 considered a favorable CIS (fCIS). All patients will be treated with EVT and medical treatment consistent with national guidelines. The primary endpoint is the clinical outcome at 90 days between fCIS group versus pCIS group. The secondary endpoint is the influence of successful revascularization on outcomes for patients with fCIS or pCIS.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

TRIPLE

Enrollment

Conditions

Acute Stroke Brain Ischemia Ischemic Stroke

Interventions

Endovascular Treatment (EVT)PROCEDURE

EVT is an endovascular procedure in which a catheter is inserted into an artery and directed to the site of the blocked blood vessel in the brain. The clot is removed using a mechanical device with or without an injection of tPA (tissue plasminogen activator) directly at the site of the clot. The protocol calls for use of the Trevo stent retriever (Stryker Neurovascular) for the first pass of clot removal.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Anterior circulation acute ischemic stroke due to blockage of the intracranial internal carotid artery or middle cerebral artery (M1) 2. Within 24 hours of onset of symptoms 3. NIHSS Score is 8 or greater Exclusion Criteria: 1. Contra-indication for IAT found on initial CT 2. Intracranial hemorrhage 3. Stroke mimics (tumor, herpetic encephalitis, etc.) 4. More than 1/3 hypodensity on non-enhanced head CT prior to intervention 5. ASPECT Score less than 6 6. Pre-existing disability defined as modified Rankin Scale (mRS) score more than 2 7. Pregnant women

Locations (6)

WellStar Atlanta Medical System

Atlanta, Georgia, United States

New York University Langone Medical Center

New York, New York, United States

Rochester General Hospital

Rochester, New York, United States

University of North Carolina Hospital

Chapel Hill, North Carolina, United States

Outcomes

Primary Outcomes

Modified Rankin Score (mRS) Between Favorable CIS Group Versus Poor CIS Group.

The mRS Score ranges from 0-6 and describes the degree of disability or dependence after a stroke. The grades are no symptoms (0), no significant disability (1), slight disability (2), moderate disability (3), moderately severe disability (4), severe disability (5), and death (6).

Time frame: 90 days

Secondary Outcomes

Complication Rate Between Favorable CIS Group Versus Poor CIS Group

Complication : Clinically relevant intracranial hemorrhage and vasogenic edema as defined by parenchymal hematoma (PH) 1 or 2

Time frame: 1 day - 1 week

Modified Rankin Score (mRS) Between Favorable CIS With Good Revascularization Versus Poor CIS With Good Revascularization.

Revascularization status will be classified as poor (mTICI = 0-2A) or good (mTICI = 2B, 3). Rate of good clinical outcomes between groups will be compared based on the combination of CIS and revascularization status. Good outcome will be measured based on the modified Rankin scale score according to: 0: No symptoms 1. No significant disability despite symptoms 2. Slight disability 3. Moderate disability 4. Moderately severe disability 5. Severe disability 6. Dead A score of 0-2 is considered a good outcome

Time frame: 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.